Shortened survival of platelets in ITP patients is attributed to the presence of IgG antibodies directed against platelet membrane glycoproteins (GPs)—especially GPIIb/IIIa and GPIb/IX/V [16]. This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.